The Online Investor
Grocery & Drug Stores M&A image Grocery & Drug Stores M&A » By The Online Investor Staff, updated Thu., Apr. 25, 2:51 AM Recent mergers and acquisitions in the Grocery & Drug Stores M&A category.

Slide #23. CVS Caremark Coram LLC

Acquirer: CVS Caremark (NYSE:CVS)
Acquiree: Coram LLC
Details: CVS Caremark announced it has entered into an agreement to acquire Coram LLC, the specialty infusion services and enteral nutrition business unit of Apria Healthcare Group Inc. for approximately $2.1 billion. Coram is one of the nation's largest providers of comprehensive infusion services, providing infusion therapies and nutrition services to more than 20,000 patients each month. Coram cares for patients primarily through home infusion as well as a national network of more than 85 locations, including more than 65 ambulatory infusion suites.

CVS Health is a health solutions company. Co.'s segments include:Health Care Benefits, which provides voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, and dental and behavioral health plans; Pharmacy Services, which provides pharmacy benefit management solutions, including plan design offerings and administration, formulary management, and retail pharmacy network management services; and Retail/Long-Term Care (LTC), which sells prescription drugs and various health and wellness products and general merchandise, provides health care services through its MinuteClinic® walk-in medical clinics and conducts LTC pharmacy operations.

CVS Health SEC Filing Email Alerts Service


Open the CVS Page at The Online Investor »

Company Name: 
CVS Health Corporation
Stock buyback: 
CVS buyback
Website: 
www.cvshealth.com
Sector: 
Diagnostics
Number of ETFs Holding CVS: 
107
Total Market Value Held by ETFs: 
$10.52B
Total Market Capitalization: 
$87.63B
% of Market Cap. Held by ETFs: 
12.00%
 

Open the CVS Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree CVS Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.34 out of 4)
49th percentile
(ranked lower than approx. 51% of all stocks covered)

Analysts' Target Price:
CVS Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Grocery & Drug Stores M&A - Slide 23 of 48 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.